Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03081910
Title	Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen (MAGENTA)
Acronym	MAGENTA
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Baylor College of Medicine
Indications	mature T-cell and NK-cell lymphoma anaplastic large cell lymphoma T-cell acute lymphoblastic leukemia mycosis fungoides prolymphocytic leukemia adult T-cell leukemia/lymphoma peripheral T-cell lymphoma Sezary's disease non-Hodgkin lymphoma angioimmunoblastic T-cell lymphoma
Therapies	CD5 CAR T cells Cyclophosphamide + Fludarabine
Age Groups:	adult \| child \| senior
Covered Countries	USA